102) individual "stress-history" of the given tumor. |
103) hell incision and completely resected the tumor. |
104) most common type of primary intracranial tumor. |
105) new possibility in the treatment of brain tumor. |
106) ed the concomitant existence of papillary tumor. |
107) vant treatment of a rectal adenocarcinoma tumor. |
108) benign, locally aggressive nasopharyngeal tumor. |
109) was interpreted as small blue round cell tumor. |
110) cinoma of the breast is an extremely rare tumor. |
111) ancers regardless of the histology of the tumor. |
112) t with growth hormone secreting pituitary tumor. |
113) findings after surgical resection of the tumor. |
114) re is no perfect single biomarker of this tumor. |
115) and ventricle due to the enlarged cardiac tumor. |
116) ained, given the aggressive nature of the tumor. |
117) od stream and nonspecific accumulation in tumor. |
118) ry saves the normal cells surrounding the tumor. |
119) SAD as one manifestation of the amygdalar tumor. |
120) uch as melanoma, neuroblastoma, and brain tumor. |
121) Tumor growth was greater in the HCT group |
122) pancreatic tumors in mice decreased both tumor growth and MUC4 mucin expression. |
123) more, miR-106b mediates TGF-β effects on tumor growth and metastasis in breast canc |
124) h IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenog |
125) ween ANG, ERK1/2 and MMP2 that can impact tumor growth and progression. |
126) The treatments significantly inhibited tumor growth and reduced tumor weight and |
127) rs, as many pathways long associated with tumor growth have been found to intersect |
128) ytic leukemia HL-60 cells and in vivo and tumor growth in a leukemia xenograft model |
129) vivo, Hhat knockdown led to reduction of tumor growth in a mouse xenograft model of |
130) colony formation and inhibited xenograft tumor growth in nude mice. |
131) vitro as well as both tumorigenicity and tumor growth in vivo, and these effects we |
132) motion of cancer cell growth in vitro and tumor growth in vivo. |
133) Rapid tumor growth with caruncular and forniceal |
134) and Juglone, a Pin1 inhibitor, abrogates tumor growth. |
|